Frontiers in Pharmaceutical Sciences Lecture Series - No. 191

Topic：Health Economic Analysis/Models and Applications In Pricing Determination， Health Technology Assessment，and Formulary Listing - Why, What, and How

Speaker：Dr. Jianwei Xuan, The Research Center of National Drug Policy and Ecosystem，China Pharmaceutical University

Chair：Prof. Min Huang, School of Pharmaceutical Science, Sun Yat-sen University  

Time：Friday, August 29th, 2014, 10:00 AM   

Venue：125 Meeting Room, School of Pharmaceutical Sciences, East Campus, SYSU

Introduction of the speaker:

Academic/contents qualifications:

1)    Ph.D. in Health Policy Administration and Health Economics. (UNC-Chapel Hill)

2)    M.S. in Pharmaceutical Marketing. (UNC-Chapel Hill)

3)    B.S. in Medicine (Shanghai Medical University)

4) Adjunct Professor, Health Policy and Health Economics, University of Florida at Gainesville, FL, USA (Advisor of multiple Ph.D. students)

5)    Advisory Professor, Fudan University, Shanghai

6) Invited Research Fellow, The Research Center of National Drug Policy and Ecosystem, China Pharmaceutical University

7) Currently hold leadership position in health policy/health economic/outcomes research international professional association such as International Society of Pharmacoeconomic Research (ISPOR). (Current Chairman of Advisory Committee/Industry Committee and Member of Executive Committee in ISPOR Asia Consortium)

8)  Recognized expert in health policy research, health economic, epidemiology, market access, and outcomes research field. Led multiple global research projects, published more than 30 scientific papers at peer reviewed international journals, and served as journal reviewer for multiple international journals.

Experience and Leadership Qualifications:

1)    More than 15 years global leadership experience to lead multiple global research teams to conduct high impact health policy researches, health economic comparative effectiveness researches, outcomes researches, epidemiology researches, and market access researches to generate population, clinical and economic evidence to support evidence based decision making process. Research results have been adapted in numerous countries to support formulating national health care policy, designing drug reimbursement formulary, and supporting government decision making etc.

2)    Established extensive professional network with global key opinion leaders in the field of health policy, health economic, and epidemiology research. Serving as leader and led numerous global policy forums, advisory boards, and government/payer panel discussions.

3)    More than 20 years research experiences with extensive publications track record in the field of health policy research, health economic comparative effectiveness researches, epidemiology researches, market access and outcomes research.

4)    Extensive teaching and graduate student advising experience in advising Ph.D. students and training government officials, researchers, and various health care service researchers.

5)    Accumulated strong negotiation and communication skills and ability to influence without authority with country policy makers to positively influence the development of heath economic and health technology assessment guidelines in countries

6)    More than 15 year Oncology research experience.

7)    Extensive health policy/health economic/epidemiology/outcomes research experience in both drug development and post marketing medical affair research and very skilled in identify product attributes, develop value positioning, develop tools/resources, and communicating with payers to support value based health care reimbursement decisions.

8)    More than 6 years Chinese FDA experience working as medical reviewers and very familiar with drug development process, global regulatory affair, and safety requirements.

All are welcome to the lecture!